Search research articles
Contact Us
Filters
Showing results (281-290 of 306) with videos related to
Page
of 31
Sort By:
Blood
|
October 18, 2011
Multi-institutional phase 2 clinical and pharmacogenomic trial of tipifarnib plus etoposide for elderly adults with newly diagnosed acute myelogenous leukemia
Judith E Karp, Tatiana I Vener, Mitch Raponi, et al.
Blood
|
December 26, 2008
Active oral regimen for elderly adults with newly diagnosed acute myelogenous leukemia: a preclinical and phase 1 trial of the farnesyltransferase inhibitor tipifarnib (R115777, Zarnestra) combined with etoposide
Judith E Karp, Karen Flatten, Eric J Feldman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 13, 2013
Myelodysplastic syndromes: clinical practice guidelines in oncology
Peter L Greenberg, Eyal Attar, John M Bennett, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 18, 2008
Myelodysplastic syndromes
Peter L Greenberg, Eyal Attar, Minoo Battiwalla, et al.
The Journal of Clinical Investigation
|
December 7, 2023
PD-1H/VISTA mediates immune evasion in acute myeloid leukemia
Tae Kon Kim, Xue Han, Qianni Hu, et al.
Leukemia & Lymphoma
|
July 3, 2018
Performance of the Medical Research Council (MRC) and the Leukemia Research Foundation (LRF) score in predicting survival benefit with hypomethylating agent use in patients with relapsed or refractory acute myeloid leukemia
Maximilian Stahl, Michelle DeVeaux, Pau Montesinos, et al.
The Journal of Biological Chemistry
|
May 3, 2011
Aberrant epigenetic and genetic marks are seen in myelodysplastic leukocytes and reveal Dock4 as a candidate pathogenic gene on chromosome 7q
Li Zhou, Joanna Opalinska, Davendra Sohal, et al.
Blood Advances
|
February 11, 2026
A novel approach to defining progression in MDS and precursor myeloid conditions in The MDS Natural History Study
Amy E DeZern, Nancy Gillis, Michael Otterstatter, et al.
Cancer
|
March 13, 2026
A phase 1 study of berzosertib (M6620, VX-970) in combination with cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma (ETCTN 9950)
Aarti Bhatia, Zhengjia Chen, Yuji Zhang, et al.
Leukemia & Lymphoma
|
May 22, 2019
The National MDS Natural History Study: design of an integrated data and sample biorepository to promote research studies in myelodysplastic syndromes
Mikkael A Sekeres, Steven D Gore, Donald M Stablein, et al.
Page
of 31
Search research articles
Search
Showing results (281-290 of 306) with videos related to
Sort By:
Page
of 31
Blood
|
October 18, 2011
Multi-institutional phase 2 clinical and pharmacogenomic trial of tipifarnib plus etoposide for elderly adults with newly diagnosed acute myelogenous leukemia
Judith E Karp, Tatiana I Vener, Mitch Raponi, et al.
Blood
|
December 26, 2008
Active oral regimen for elderly adults with newly diagnosed acute myelogenous leukemia: a preclinical and phase 1 trial of the farnesyltransferase inhibitor tipifarnib (R115777, Zarnestra) combined with etoposide
Judith E Karp, Karen Flatten, Eric J Feldman, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 13, 2013
Myelodysplastic syndromes: clinical practice guidelines in oncology
Peter L Greenberg, Eyal Attar, John M Bennett, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 18, 2008
Myelodysplastic syndromes
Peter L Greenberg, Eyal Attar, Minoo Battiwalla, et al.
The Journal of Clinical Investigation
|
December 7, 2023
PD-1H/VISTA mediates immune evasion in acute myeloid leukemia
Tae Kon Kim, Xue Han, Qianni Hu, et al.
Leukemia & Lymphoma
|
July 3, 2018
Performance of the Medical Research Council (MRC) and the Leukemia Research Foundation (LRF) score in predicting survival benefit with hypomethylating agent use in patients with relapsed or refractory acute myeloid leukemia
Maximilian Stahl, Michelle DeVeaux, Pau Montesinos, et al.
The Journal of Biological Chemistry
|
May 3, 2011
Aberrant epigenetic and genetic marks are seen in myelodysplastic leukocytes and reveal Dock4 as a candidate pathogenic gene on chromosome 7q
Li Zhou, Joanna Opalinska, Davendra Sohal, et al.
Blood Advances
|
February 11, 2026
A novel approach to defining progression in MDS and precursor myeloid conditions in The MDS Natural History Study
Amy E DeZern, Nancy Gillis, Michael Otterstatter, et al.
Cancer
|
March 13, 2026
A phase 1 study of berzosertib (M6620, VX-970) in combination with cisplatin and radiation in patients with locally advanced head and neck squamous cell carcinoma (ETCTN 9950)
Aarti Bhatia, Zhengjia Chen, Yuji Zhang, et al.
Leukemia & Lymphoma
|
May 22, 2019
The National MDS Natural History Study: design of an integrated data and sample biorepository to promote research studies in myelodysplastic syndromes
Mikkael A Sekeres, Steven D Gore, Donald M Stablein, et al.
Page
of 31